BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Leukocyte, Laser capture microdissection, Acetaminophen, rs2300478, PDX1, Influenza)
Bookmark Forward

QuickView for ribonuclease inhibitor;jsessionid=852236968D0BEB19CC86CF70D8D4015F;jsessionid=CA100C2C5F46F49CA95E857522ADC05F;jsessionid=E949B8FFB5F7FF0D1494DA3984B71DC0;jsessionid=691D34C9BCAC3A704F853FB2519E3B4E;jsessionid=EDABE7483C5635315DEE4A5D5039C889 (gene)


Body Atlas

Most Correlated Tissues

  1. Macrophage of peripheral blood
  2. Microglial cell
  3. Myeloid cells of peripheral blood
  4. Oral mucosa
  5. Nipple cross-section
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Injury of eye region
  2. Disorder related to transplantation
  3. 11p partial monosomy syndrome
  4. Disorder of brain
  5. Infection due to Staphylococcus aureus
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. rofecoxib
  2. Sucrose
  3. Ritonavir
  4. Diphenhydramine
  5. Rifampin
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. SMYD2
  2. DYNLT3
  3. RNH1
  4. SLC25A4
  5. LEP
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

There were no matches for ribonuclease inhibitor;jsessionid=852236968D0BEB19CC86CF70D8D4015F;jsessionid=CA100C2C5F46F49CA95E857522ADC05F;jsessionid=E949B8FFB5F7FF0D1494DA3984B71DC0;jsessionid=691D34C9BCAC3A704F853FB2519E3B4E;jsessionid=EDABE7483C5635315DEE4A5D5039C889
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for ribonuclease inhibitor;jsessionid=852236968D0BEB19CC86CF70D8D4015F;jsessionid=CA100C2C5F46F49CA95E857522ADC05F;jsessionid=E949B8FFB5F7FF0D1494DA3984B71DC0;jsessionid=691D34C9BCAC3A704F853FB2519E3B4E;jsessionid=EDABE7483C5635315DEE4A5D5039C889
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.